scholarly journals Multifunctional Polymer Nanoparticles for Dual Drug Release and Cancer Cell Targeting

Polymers ◽  
2017 ◽  
Vol 9 (12) ◽  
pp. 213 ◽  
Author(s):  
Yu-Han Wen ◽  
Tsung-Ying Lee ◽  
Ping-Chuan Fu ◽  
Chun-Liang Lo ◽  
Yi-Ting Chiang
2012 ◽  
Vol 22 (31) ◽  
pp. 16078 ◽  
Author(s):  
Xinxin Qiang ◽  
Tong Wu ◽  
Jiangli Fan ◽  
Jingyun Wang ◽  
Fengling Song ◽  
...  

2019 ◽  
Vol 206 ◽  
pp. 694-705 ◽  
Author(s):  
Manita Das ◽  
Archana Solanki ◽  
Apeksha Joshi ◽  
Ranjitsinh Devkar ◽  
Sriram Seshadri ◽  
...  

2018 ◽  
Vol 54 (90) ◽  
pp. 12762-12765 ◽  
Author(s):  
Wei Qi Lim ◽  
Soo Zeng Fiona Phua ◽  
Hongzhong Chen ◽  
Yanli Zhao

A two-component supramolecular prodrug nanocarrier fabricated via self-assembly presents redox-responsive drug release with cancer cell-targeting capability, showing enhanced efficiency for colorectal cancer treatment.


2018 ◽  
Vol 5 (1) ◽  
pp. 170986 ◽  
Author(s):  
Yang Zhang ◽  
Juan Xu

This paper proposes a novel type of multifunctional envelope-type mesoporous silica nanoparticle (MSN) to achieve cancer cell targeting and drug-controlled release. In this system, MSNs were first modified by active targeting moiety hyaluronic acid (HA) for breast cancer cell targeting and hyaluronidases (Hyal)-induced intracellular drug release. Then gelatin, a proteinaceous biopolymer, was grafted onto the MSNs to form a capping layer via glutaraldehyde-mediated cross-linking. To shield against unspecific uptake of cells and prolong circulation time, the nanoparticles were further decorated with poly(ethylene glycol) polymers (PEG) to obtain MSN@HA-gelatin-PEG (MHGP). Doxorubicin (DOX), as a model drug, was loaded into PEMSN to assess the breast cancer cell targeting and drug release behaviours. In vitro study revealed that PEG chains protect the targeting ligand and shield against normal cells. After reaching the breast cancer cells, MMP-2 overpressed by cells hydrolyses gelatin layer to deshield PEG and switch on the function of HA. As a result, DOX-loaded MHGP was selectively trapped by cancer cells through HA receptor-mediated endocytosis and subsequently release DOX due to Hyal-catalysed degradation of HA. This system presents successful bienzyme-responsive targeting drug delivery in an optimal fashion and provides potential applications for targeted cancer therapy.


RSC Advances ◽  
2021 ◽  
Vol 11 (26) ◽  
pp. 16131-16141
Author(s):  
Manali Haniti Mohd-Zahid ◽  
Siti Nadiah Zulkifli ◽  
Che Azurahanim Che Abdullah ◽  
JitKang Lim ◽  
Sharida Fakurazi ◽  
...  

5-FU-PEGylated AuNPs-CD133 is designed to improve specific targeting of 5-FU against colorectal cancer cells which abundantly express CD133.


2016 ◽  
Vol 111 ◽  
pp. 155-162 ◽  
Author(s):  
Elisabetta Galbiati ◽  
Luca Gambini ◽  
Viola Civitarese ◽  
Michela Bellini ◽  
Dario Ambrosini ◽  
...  

2018 ◽  
Vol 52 ◽  
pp. 17-25 ◽  
Author(s):  
Bhupender Sharma ◽  
Shamsher S. Kanwar

2013 ◽  
Vol 24 (12) ◽  
pp. 1772-1780 ◽  
Author(s):  
Chunmei Li ◽  
Tao Chen ◽  
Ismail Ocsoy ◽  
Guizhi Zhu ◽  
Emir Yasun ◽  
...  

Author(s):  
M. Carmen Estévez ◽  
Yu-Fen Huang ◽  
Huaizhi Kang ◽  
Meghan B. O’Donoghue ◽  
Suwussa Bamrungsap ◽  
...  

2018 ◽  
Vol 10 (4) ◽  
pp. 3305-3313 ◽  
Author(s):  
Bilal Demir ◽  
Michael M. Lemberger ◽  
Maria Panagiotopoulou ◽  
Paulina X. Medina Rangel ◽  
Suna Timur ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document